Skip to search formSkip to main contentSkip to account menu

NSC 287513

Known as: NSC-287513 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ametantrone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1981
1981
Phase I clinical trial with anthracenedione diacetate (DAD) (NSC-287513)
1980
1980
Pharmacological disposition of 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate in the dog.
1,4-Bis (2-[(2-hydroxyethyl)amino]ethylamino)-9,10-anthracenedione (NSC 287513) (HAQ) may be selected for clinical trial based on…